Valuation : SSY Group Limited

Market Cap 7.62B 972M 836M 788M 718M 1.34B 92.9B 1.35B 9.39B 3.61B 47.12B 3.65B 3.57B 150B P/E 2026 *
13.2x
P/E 2027 * 11.5x
Enterprise Value 7.62B 972M 836M 788M 718M 1.34B 92.9B 1.35B 9.39B 3.61B 47.12B 3.65B 3.57B 150B EV / Sales 2026 *
1.62x
EV / Sales 2027 * 1.47x
Free-Float
33.26%
Yield 2026 *
4.17%
Yield 2027 * 4.93%
1 day-2.23%
1 week-3.48%
Current month-2.59%
1 month+9.79%
3 months+15.57%
6 months+4.98%
Current year-6.89%
1 week 2.58
Extreme 2.58
2.77
1 month 2.38
Extreme 2.385
2.78
Current year 2.01
Extreme 2.01
3.15
1 year 2.01
Extreme 2.01
3.18
3 years 2.01
Extreme 2.01
5.2
5 years 2.01
Extreme 2.01
5.68
10 years 2.01
Extreme 2.01
9.46
Manager TitleAgeSince
Chief Executive Officer 69 2010-03-22
Director of Finance/CFO 45 2015-03-31
Corporate Officer/Principal 42 2024-08-27
Director TitleAgeSince
Chairman 69 2014-06-03
Director/Board Member 61 2007-07-25
Director/Board Member 57 2005-10-15
Date Insider Type Main position Quantity % Market Cap. Importance
9/4/26 Other

Chief Executive Officer

850,000 0.0288%
5/21/26 Other

Chief Executive Officer

1,300,000 0.0441%
5/19/26 Other

Chief Executive Officer

2,000,000 0.0678%
Change 5-day change 1-year change 3-year change Capi.($)
-0.19%-3.48%-15.27%-38.00% 994M
-0.11%-3.20%+49.61%+91.49% 1,002B
-0.27%-3.22%+50.51%+65.89% 644B
+1.63%-2.57%+21.19%+71.12% 443B
-0.63%-1.06%+28.11%+34.59% 343B
+0.43%-14.61%+9.88%+27.26% 262B
+0.93%-1.82%-1.82%+8.41% 245B
-2.25%-13.63%+36.61%+47.43% 212B
-0.90%-5.09%-15.47%-57.75% 199B
-0.58%-3.21%+25.10%+90.54% 181B
Average -0.07%-4.62%+18.84%+34.10% 353.07B
Weighted average by Cap. +0.39%-4.24%+31.89%+57.09%

Financials

2026 *2027 *
Net sales 4.71B 601M 516M 487M 444M 830M 57.41B 837M 5.8B 2.23B 29.12B 2.26B 2.21B 92.5B 5.18B 661M 568M 536M 488M 913M 63.17B 921M 6.38B 2.46B 32.04B 2.48B 2.43B 102B
Net income 601M 76.71M 65.97M 62.24M 56.7M 106M 7.33B 107M 741M 285M 3.72B 288M 282M 11.82B 676M 86.26M 74.18M 69.99M 63.76M 119M 8.25B 120M 834M 321M 4.18B 324M 317M 13.29B
Net Debt - -
Logo SSY Group Limited
SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.
Employees
5,400
Date Price Change Volume
26-09-10 HK$2.635 -0.19% 4,294,000
26-09-09 HK$2.695 -0.74% 4,470,000
26-09-08 HK$2.715 -0.91% 5,768,000
26-09-07 HK$2.740 +0.37% 3,164,000
26-09-04 HK$2.730 -0.18% 3,502,000
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.635HKD
Average target price
3.925HKD
Spread / Average Target
+48.96%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2005 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!